Harvard Bioscience (HBIO) Amortizatization of Intangibles (2017 - 2026)

Harvard Bioscience (HBIO) has 10 years of Amortizatization of Intangibles data on file, last reported at $907000.0 in Q1 2026.

• On a quarterly basis, Amortizatization of Intangibles fell 24.67% year-over-year to $907000.0 in Q1 2026; TTM through Mar 2026 was $3.9 million, a 25.33% decrease from a year earlier, with the FY2025 full-year figure at $4.2 million, down 22.22% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $907000.0, up from $892000.0 in the prior quarter.
• Over the last five years, Amortizatization of Intangibles for HBIO reached as high as $1.6 million in Q4 2022 and fell as low as $892000.0 in Q4 2025.
• Historically, Amortizatization of Intangibles has averaged $1.3 million across 5 years, with a median of $1.4 million in 2024.
• Across the five-year window, Amortizatization of Intangibles gained 12.26% in 2022 and sank 34.76% in 2025, its largest moves.
• Year by year, Amortizatization of Intangibles stood at $1.6 million in 2022, then slipped by 16.44% to $1.4 million in 2023, then fell by 6.68% to $1.3 million in 2024, then fell by 29.82% to $892000.0 in 2025, then gained by 1.68% to $907000.0 in 2026.
• Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $907000.0 in Q1 2026, $892000.0 in Q4 2025, and $899000.0 in Q3 2025.